Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Age
18–73
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Primary tumor resected according to standard oncological practice, p≤T4a, R0 resection
Colorectal liver metastasis considered as non-resectable either up-front or after previous hepatic resections
No local recurrence of primary colon cancer confirmed by Positron Emission Tomography, Computed Tomography and colonoscopy
No extra-hepatic metastatic disease confirmed by Positron Emission Tomography and Computed Tomography
Good performance status Eastern Cooperative Oncology Group 0 or 1
Neutrophils \> 1.000
Patients who received at least one line of chemotherapy for at least 3 months with partial response or stable disease according to modified Response Evaluation Criteria in Solid Tumours
Carcino-Embryonic Antigen \< 80 µg/L or reduction of ≥ 50% of highest Carcino-Embryonic Antigen level observed
Written informed consent
No other contraindications to liver transplantation
You may not be if
Presence of other malignancies
Local recurrence of primary tumor
Extra-hepatic metastatic disease
Patients who did not receive any neoadjuvant or adjuvant therapy
Palliative resection of primary tumor
Any other reason, according to the investigators, that could be a contraindication to protocol enrollment
